Future prospective studies are needed to confirm the association between anti-HBc positivity and treatment resistance in AIH, evaluate the role of antiviral prophylaxis in improving treatment response, and explore immunopathological mechanisms underlying the interaction between latent HBV and autoimmunity. The gene discussed is KRT88P; the disease is Autoimmunity.